In contrast, Ryu et al. [25] compared molecular alteration and tumor immunity in young (<45 years) and old (≥45 years) HNSCC patients and found that PD-L1 positivity was more frequent in the younger aged group (p = 0.01), similar to the results in this study. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.